luckme
commented on
2
3
luckme
commented on
$Allarity Therapeutics(ALLR.US$ remember, please place stop loss. if any9ne need help you can request for my number. ops. don't forget to read your Bible. if you need to blow the dust off of it. that's all right. God look at tour heart. remember. anything. you going threw or someone you no. talk to Jesus Christ. he can fix it. he is better than Bob, the builder. love ye one another. never hate, no one. and watch how you speak to children and grow up. PLEASEEEE. IF YOU SEE AN OL...
![Picture](https://ussnsimg.moomoo.com/sns_client_feed/73909932/20240628/1719510670614-random7844-73909932-android-compress.jpg/thumb?area=100&is_public=true)
![Picture](https://ussnsimg.moomoo.com/sns_client_feed/73909932/20240628/1719510677302-random1781-73909932-android-compress.jpg/thumb?area=100&is_public=true)
![Picture](https://ussnsimg.moomoo.com/sns_client_feed/73909932/20240628/1719510681419-random6786-73909932-android-compress.jpg/thumb?area=100&is_public=true)
+3
1
1
luckme
commented on
$Allarity Therapeutics(ALLR.US$ $Allarity Therapeutics(ALLR.US$ don't buy this they filling bankruptcy
![Picture](https://ussnsimg.moomoo.com/sns_client_feed/73909932/20240628/1719513444460-random8082-73909932-android-compress.jpg/thumb?area=100&is_public=true)
2
luckme
liked
$Allarity Therapeutics(ALLR.US$ They have already done 3 R/S’s in 15 months for a total of 95-1! IMO Nasdaq will look at that and i believe there is a chance they get turned down? I really hope im wrong! This company has a nice pipeline! Its biggest problem with price is SS’s and naked shorts!
4
8
$Allarity Therapeutics(ALLR.US$ On June 25, 2024, the clinical-stage biopharmaceutical company Allarity Therapeutics announced that the drug stenoparib, which treats the inverted symptoms of sterile ovarian cancer by Evans Holdings, has made significant progress in its phase II clinical trial. The trial showed that several patients had been treated for more than 30 weeks, indicating that the drug had long-term clinical benefits. This was a further announcement following an earlier statement in May 2024 showing that stenoparib had significant tumor shrinkage and long-term disease stability in heavily pretreated patients. The company has decided to discontinue patient recruitment and focus on a follow-up trial aimed at speeding up stenoparib's passage through regulatory approval. The trial's lead researcher Kathryn N. Moore, MD, emphasized the need to continue developing next-generation PARP inhibitors like stenoparib. CEO Thomas Jensen emphasized the drug's good safety and its potential as a next-generation treatment option. The company plans to present detailed test data at high-level scientific meetings, adhering to the usual rules for such events. The PARP inhibitor market is expected to reach $22 billion in 2028, and there is great interest in drugs with better tolerability and safety. Due to its dual inhibitory activity and safety...
Translated
$Allarity Therapeutics(ALLR.US$ Oh my gosh, the shares were only merged in April. Will it take another joint stock to meet the standards? The second phase of its research has already been successful and finished early; it's not enough to support the stock price increase. It's really sad
Translated
1
luckme
commented on
$Allarity Therapeutics(ALLR.US$ It seems like they are going to do an R/S
1
1
$Zapata Computing(ZPTA.US$ As an industrial intelligence stock, why has it been sold off since it went public? Doesn't it have any value? Can anyone tell me why, thank you
Translated
1
luckme
commented on
$Zapata Computing(ZPTA.US$ It's about to be delisted
Translated
2
16
luckme
commented on
$Cassava Sciences(SAVA.US$ SAVA Fin. Update: “an internal investigation conducted by outside counsel Orrick LLP engaged by BOD has found no evidence to substantiate allegations that the Company or its employees engaged in or were aware of research misconduct.”
![Picture](https://ussnsimg.moomoo.com/sns_client_feed/71846513/20240611/6ffddad0e6f41dfd0e310003d31a0063.jpg/thumb?area=100&is_public=true)
1
1
luckme FattyChick : I read his post. I bought both stocks and got scammed, and I haven't turned around until now